It is noteworthy that during the four-week active insulin therapy period of the study, sham control mice lost body weight, possibly due to the catabolic state of the diabetes (and possibly injection-related stresses), while the insulin-treated mice were still on the HFD and gained a slight amount of weight. The gene discussed is INS; the disease is diabetes mellitus.